Verrica Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2025.
  • Verrica Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 9.49M shares, a 103% increase year-over-year.
  • Verrica Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 51.8M shares, a 14.3% increase from 2023.
  • Verrica Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 45.3M shares, a 32.7% increase from 2022.
  • Verrica Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 34.2M shares, a 26.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Verrica Pharmaceuticals Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 9.49M +4.81M +103% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 9.49M +4.84M +104% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 94.8M +48.4M +104% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 51.8M +6.47M +14.3% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-11
Q3 2024 4.68M -41.4M -89.8% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 4.65M -41.3M -89.9% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 46.5M +3.46M +8.04% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 45.3M +11.2M +32.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-11
Q3 2023 46.1M +5.77M +14.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 45.9M +18.4M +66.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 43M +15.5M +56.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 34.2M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 40.3M +12.8M +46.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 27.5M +5.39K +0.02% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 27.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 27.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 27.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11

Verrica Pharmaceuticals Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 51.8M +6.47M +14.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 45.3M +11.2M +32.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 34.2M +7.12M +26.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 27M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.